Gene · 4017
Papers2,536
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,536
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LOXL2-mediated chromatin compaction is required to maintain the oncogenic properties of triple-negative breast cancer cells. | FEBS J | 2024 | 38451841 | PubTator, text mining | PubMed |
| Increased LOXL2 expression is related to poor prognosis in lung squamous cell carcinoma. | J Thorac Dis | 2024 | 38410543 | PubTator, text mining | PubMed |
| TGF-β2-induced alterations of m6A methylation in hTERT RPE-1 cells. | Exp Eye Res | 2024 | 38395214 | PubTator, text mining | PubMed |
| Transcriptomic evaluation of skin tape-strips in children with allergic asthma uncovers epidermal barrier dysfunction and asthma-associated biomarkers abnormalities. | Allergy | 2024 | 38375886 | PubTator, text mining | PubMed |
| RNA-binding protein RPS7 promotes hepatocellular carcinoma progression via LOXL2-dependent activation of ITGB1/FAK/SRC signaling. | J Exp Clin Cancer Res | 2024 | 38326908 | PubTator, text mining | PubMed |
| Knockdown of Hyaluronan synthase 2 suppresses liver fibrosis in mice via induction of transcriptomic changes similar to 4MU treatment. | Sci Rep | 2024 | 38307876 | PubTator, text mining | PubMed |
| Identification of biomarker candidates for exfoliative glaucoma from autoimmunity profiling. | BMC Ophthalmol | 2024 | 38287276 | PubTator, text mining | PubMed |
| LOX, but not LOXL2, promotes bone metastasis formation and bone destruction in triple-negative breast cancer. | J Bone Oncol | 2024 | 38283827 | PubTator, text mining | PubMed |
| A single-cell atlas of conventional central chondrosarcoma reveals the role of endoplasmic reticulum stress in malignant transformation. | Commun Biol | 2024 | 38267611 | PubTator, text mining | PubMed |
| The Inhibition of Vessel Co-Option as an Emerging Strategy for Cancer Therapy. | Int J Mol Sci | 2024 | 38255995 | PubTator, text mining | PubMed |
| Differential Gene Expression in Human Fibroblasts Simultaneously Exposed to Ionizing Radiation and Simulated Microgravity. | Biomolecules | 2024 | 38254688 | PubTator, text mining | PubMed |
| SGK1 aggravates idiopathic pulmonary fibrosis by triggering H3k27ac-mediated macrophage reprogramming and disturbing immune homeostasis. | Int J Biol Sci | 2024 | 38250161 | PubTator, text mining | PubMed |
| Matrix stiffness affects tumor-associated macrophage functional polarization and its potential in tumor therapy. | J Transl Med | 2024 | 38246995 | PubTator, text mining | PubMed |
| CEBPA facilitates LOXL2 and LOXL3 transcription to promote BCL-2 stability and thus enhances the growth and metastasis of lung carcinoma cells in vitro. | Exp Cell Res | 2024 | 38242344 | PubTator, text mining | PubMed |
| Effect of traditional Chinese medicine in osteosarcoma: Cross-interference of signaling pathways and potential therapeutic targets. | Medicine (Baltimore) | 2024 | 38241548 | PubTator, text mining | PubMed |
| Unveiling breast cancer metastasis through an advanced X-ray imaging approach. | Sci Rep | 2024 | 38228854 | PubTator, text mining | PubMed |
| Relevance Analysis of TPM2 and Clinicopathological Characteristics in Breast Cancer. | Int J Gen Med | 2024 | 38221941 | PubTator, text mining | PubMed |
| Emerging roles of exosomes in oral diseases progression. | Int J Oral Sci | 2024 | 38221571 | PubTator, text mining | PubMed |
| Mechanism of lysine oxidase-like 1 promoting synovial inflammation mediating rheumatoid arthritis development. | Aging (Albany NY) | 2024 | 38217541 | PubTator, text mining | PubMed |
| Relationship between Biochemical Pathways and Non-Coding RNAs Involved in the Progression of Diabetic Retinopathy. | J Clin Med | 2024 | 38202299 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4017/papers?page=10